| Jun 28 |
Positive Results from Osteoarthritis Clinical Study in Dogs Reported by Can-Fite’s Partner Vetbiolix
|
| Jun 24 |
Can-Fite: Breakthrough Findings Demonstrate Namodenoson Anti-cancer and Protective Effect Mechanism in the Liver
|
| Jun 10 |
Can-Fite Received IRB Approval for the Treatment of Pancreatic Cancer with Namodenoson in a Phase IIa Study
|
| Jun 5 |
Can-Fite Updates on its Advanced Liver Cancer Pivotal Phase 3 Study
|
| May 29 |
Independent Scientists Published a Review Article Demonstrating That Can-Fite Drugs Have Therapeutic Effects on Heart Diseases
|
| May 27 |
Can-Fite to Participate in Partnering Meetings at Bio International Convention 2024
|
| May 23 |
Join Can-Fite’s Exclusive Live Investor Webinar and Q&A Session on June 6
|
